FOCAL EPILEPSY WITH AND WITHOUT SECONDARY GENERALIZATION
Clinical trials for FOCAL EPILEPSY WITH AND WITHOUT SECONDARY GENERALIZATION explained in plain language.
Never miss a new study
Get alerted when new FOCAL EPILEPSY WITH AND WITHOUT SECONDARY GENERALIZATION trials appear
Sign up with your email to follow new studies for FOCAL EPILEPSY WITH AND WITHOUT SECONDARY GENERALIZATION, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New epilepsy drug under Real-World watch: can cenobamate tame stubborn seizures?
Disease control Recruiting nowThis study tracks 300 adults with focal epilepsy whose seizures are not well controlled despite trying 2 or 3 other medications. Researchers will observe how adding cenobamate to their treatment affects seizure frequency over 6 to 12 months in everyday medical practice across Fra…
Matched conditions: FOCAL EPILEPSY WITH AND WITHOUT SECONDARY GENERALIZATION
Sponsor: Aziende Chimiche Riunite Angelini Francesco S.p.A • Aim: Disease control
Last updated May 17, 2026 06:50 UTC
-
Brain surgery for epilepsy: how does it affect your mind and mood?
Knowledge-focused Recruiting nowThis study looks at the mental health, emotions, and quality of life of 180 adults with hard-to-treat focal epilepsy who are eligible for brain surgery. Researchers will track changes in mood, anxiety, irritability, and other psychological factors before and after surgery. The go…
Matched conditions: FOCAL EPILEPSY WITH AND WITHOUT SECONDARY GENERALIZATION
Phase: NA • Sponsor: Fondazione I.R.C.C.S. Istituto Neurologico Carlo Besta • Aim: Knowledge-focused
Last updated May 12, 2026 13:44 UTC